Latest Health And Wellness News

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.

Holista Colltech has confirmed Leong Man Loong as its permanent CEO, cementing leadership stability during a pivotal recovery phase. His symbolic $1 salary underscores a commitment to long-term growth.

Thrive Tribe Technologies has announced a proposed 20, 1 share consolidation aimed at streamlining its capital structure, pending shareholder approval at the upcoming Extraordinary General Meeting.

EZZ Life Science has inked a three-year distribution deal with ROFA Enterprises, marking a significant step into Southeast Asia’s booming health market. The agreement guarantees at least A$21 million in sales across Thailand, Vietnam, and Singapore.

EVE Health Group has initiated stability testing for its novel oral treatments targeting erectile dysfunction and dysmenorrhea, marking a crucial step toward regulatory approval in Australia. The company also finalizes its acquisition of Nextract, the developer behind these innovative formulations.

Viva Leisure has taken a strategic 33% stake in Gorilla X Labs, aiming to deepen its footprint in the sports nutrition market and enhance member offerings across its platforms.

Elixinol Wellness Ltd has raised $1.5 million through a mix of debt and equity to boost automation and expand its key brands, including Healthy Chef and Soul Seeds.

Elixinol Wellness Limited reported a robust FY24 performance, achieving an 81% increase in revenue and significantly narrowing its losses. The company is now focused on scaling its direct-to-consumer channels and operational efficiencies to reach profitability in 2025.

Biome Australia is expanding its health portfolio with Activated Therapeutics, a new practitioner-only brand launching four evidence-based natural medicine products in Q4 2025.